Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Authors:
- I.E. ZühlkeIZI.E. Zühlke
- F. KanniessFKF. Kanniess
- K. RichterKRK. Richter
- D. Nielsen-GodeDND. Nielsen-Gode
- S. BöhmeSBS. Böhme
- R.A. JörresRJR.A. Jörres
- H. MagnussenHMH. Magnussen
- 1 December 2003
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 22 (6) , 926-930
Abstract
This study assessed the effect of the leukotriene receptor antagonist montelukast on hypertonic saline-induced airway obstruction.A total of 29 patients with chronic obstructive pulmonary disease (forced expiratory volume in one second (FEV1), 42±4% predicted) received either 10 mg montelukast and 3 h later placeboviametered-dose inhaler (MDI) (M), or placebo and 3h later 200 µg salbutamol (S), or two doses of placebo (P), in a randomised order. Patients inhaled salbutamol 1 h after MDI and the challenge was performed 15 min later (3% saline, 5 min). Data are given as per cent changesversusbaseline.Compared to P, S caused significant bronchodilation in FEV1(7.3%) and forced inspiratory volume in one second (FIV1) (4.5%), and M in FIV1(1.5%). The saline-induced fall in FEV1was lower after M (−5.8%), compared with S (−10.3%) and P (−13.1%). FEV1(11.3%) and FIV1(7.6%) was improved over baseline after recovery by M but not P and S. Recovery times regarding FEV1(8.5 min) and FIV1(15.2 min) were shortest after M, respective values for S being 16.8 and 20.4 min, and for P 15.9 and 21.2 min. Effects were strongest in patients with low baseline FEV1and/or inhaled corticosteroids.Data from this study indicate beneficial effects of montelukast on hypertonic saline-induced airway responses in patients with chronic obstructive pulmonary disease, particularly those with severe disease. The major effect was an accelerated recovery leading to values above baseline.Keywords
This publication has 25 references indexed in Scilit:
- Anti-inflammatory and Lung Function Effects of Montelukast in Asthmatic Volunteers Exposed to Sulfur DioxideChest, 2001
- Update on sputum methodologyEuropean Respiratory Journal, 2000
- Safety of sputum induction in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2000
- Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5′‐monophosphate‐induced bronchoconstriction in patients with COPDClinical & Experimental Allergy, 1999
- Changes in sputum composition during sputum induction in healthy and asthmatic subjectsClinical & Experimental Allergy, 1998
- The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstriction in asthmaJournal of Allergy and Clinical Immunology, 1993
- Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction.Thorax, 1987
- Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency.Thorax, 1982
- ST. THOMAS'S HOSPITAL.The Lancet, 1824